CNBC's "Fast Money" cover image

CNBC's "Fast Money"

Latest episodes

undefined
12 snips
Dec 11, 2024 • 44min

Nasdaq Hits 20,000 For First Time Ever… And Nuclear’s Renaissance Description 12/11/24

The Nasdaq's historic leap past 20,000 showcases a tech-driven surge, raising questions about sustainable growth amid inflation. Their discussion pivots to the rising demand for nuclear energy, fueled by AI data centers, highlighting innovations in uranium mining. An exclusive look at a deep Canadian mine reveals cutting-edge extraction tech. Meanwhile, the challenges of major software firms contrast with booming sectors like autonomous vehicles and strategic healthcare partnerships, reshaping investment landscapes.
undefined
12 snips
Dec 10, 2024 • 44min

Google’s Quantum Computing Breakthrough… And Health Insurers In The Spotlight 12/10/24

Shares of Alphabet surging as Google unveils a ‘breakthrough’ quantum computing chip. What it means for the future of coding, and the areas of tech that could benefit. Plus A spotlight on the health insurance space, as the suspect in the UNH CEO murder investigation heads to his first court appearance. The latest details on his motives, and how it could all impact other players in the health insurance space.Fast Money Disclaimer
undefined
Dec 9, 2024 • 44min

Red-Hot Reversals… And AI’s Impact On The Insurance Space 12/9/24

This discussion dives into the hot stock reversals affecting tech, restaurants, and asset managers. It also sheds light on a high-profile murder investigation in the insurance sector and how AI is altering claim processes, leading to increased denials. The episode touches on Oracle's stock struggles amid market volatility and the impact of China's currency devaluation on key industries. Additionally, it examines the resilience of luxury home builders in a challenging economic landscape.
undefined
9 snips
Dec 6, 2024 • 44min

Appeals Court Upholds TikTok Ban… And UnitedHealth’s Worst Week Since 2020 12/6/24

A federal appeals court ruling may lead to a TikTok ban, potentially benefiting rivals like Meta and Snap. The discussion dives into the geopolitical implications and how energy stocks are faring in this volatile environment. Meanwhile, UnitedHealth faces its worst week since 2020 following a tragic event within its leadership. Lululemon shines with significant earnings growth, while Dollar General sees a stock surge amidst market fluctuations. The need for greater transparency in insurance practices is highlighted as scrutiny on companies increases.
undefined
8 snips
Dec 5, 2024 • 44min

Countdown To November Jobs Report… And Bitcoin Breaks Above $100,000 12/5/24

Attention turns to the upcoming November jobs report as stocks pause their rally. Bitcoin captures the spotlight, finally breaking the $100,000 barrier, stirring excitement among retail investors. Amid market insights, the conversation navigates the performance of various sectors, including the resilience of Lululemon. Meanwhile, Waymo's expansion into Miami raises questions about the future of ride-hailing companies. Finally, advancements in obesity treatments highlight new opportunities within the healthcare market.
undefined
Dec 4, 2024 • 1h 10min

Tech Strength Drives Rally… And Eli Lilly Beats Out The Competition 12/4/24

In this engaging discussion, Jeff Bezos, founder and executive chairman of Amazon, shares insights on big tech's impact on market surges, particularly in software and semiconductors. He reflects on Eli Lilly's groundbreaking obesity drug Zepbound and its competitive edge against Novo's Wegovy. The conversation also touches on the future of space exploration, highlighting the Moon as a launchpad for adventures to Mars, and the transformative role of AI in reshaping industries. Bezos emphasizes innovation's importance in navigating economic challenges.
undefined
8 snips
Dec 3, 2024 • 44min

The Latest U.S.-China Tit-For-Tat… And Fast Money’s Obesity Week Continues 12/3/24

Tensions between the U.S. and China escalate as trade restrictions heat up, but there's talk of potential opportunities in Chinese stocks. The biotech sector shines with innovations in obesity drugs, particularly a promising new treatment entering phase three trials. Insights from major companies like Salesforce and AT&T showcase market shifts driven by AI advancements and strategic investments. The discussion wraps up with analysis on holiday shopping trends and technology's influence on consumer behavior.
undefined
9 snips
Dec 2, 2024 • 44min

Intel CEO Stepping Down… And Fast Money’s Obesity Week Kicks Off 12/2/24

Intel's CEO is stepping down amid stock struggles and a need for innovation, prompting discussions on the company's turnaround strategies. The podcast highlights the surge in the obesity drug market, especially GLP-1 drugs, and investment potential. Retail trends post-Thanksgiving look promising, with strong performances in holiday shopping and record box office earnings boosting Disney. Political impacts on healthcare and tech, alongside Apple's reliance on Chinese manufacturing, underscore pressing market challenges.
undefined
10 snips
Nov 27, 2024 • 44min

State Of The Consumer Ahead Of Black Friday… And Markets Into Year End 11/27/24

Naveen Jaggi, America's president of retail advisory services at JLL, shares valuable insights into the retail landscape as consumers approach Black Friday. He discusses how lower gas prices and inflation are boosting consumer confidence, highlighting the contrasting fortunes of major retailers versus dollar stores. The conversation includes the anticipated surge in in-store shopping and the strategies that retailers must adopt. Additionally, they touch on Bitcoin's recent volatility and its impact on market trends as year-end approaches.
undefined
Nov 26, 2024 • 44min

2025 IPO Predictions, Tariff Risks 11/26/24

The podcast dives into the potential effects of the president-elect's proposed tariffs on trade relationships with key countries like Mexico and China. It examines tech market performances, focusing on companies like Dell and NVIDIA amidst supply chain challenges. CrowdStrike's strong earnings report faces scrutiny due to a global tech outage. There's an analysis of the surge in stock indices alongside Amgen's disappointing obesity drug trial. The discussion wraps up with insights on IPO dynamics and trends in the retail sector, highlighting shifting consumer behaviors.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode